Erika Halášová
- Chemical Health and Safety top 5%
-
- Neuroscience of respiration and sleep 8
- Pharmacy top 2%
- Infant Health and Development 7
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 6
- MicroRNA in disease regulation 5
- Rheumatology top 5%
-
- Metabolomics and Mass Spectrometry Studies 7
- DNA Repair Mechanisms 6
- Epigenetics and DNA Methylation 6
-
- Respiratory and Cough-Related Research 7
Erika Halášová
78 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Chemical Health and Safety 18
- Endocrine and Autonomic Systems 172
- Pharmacy 96
- Cancer Research 246
- Rheumatology 210
Countries citing papers authored by Erika Halášová
This map shows the geographic impact of Erika Halášová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Halášová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Halášová more than expected).
Fields of papers citing papers by Erika Halášová
This network shows the impact of papers produced by Erika Halášová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Halášová. The network helps show where Erika Halášová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erika Halášová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 8 | |
| 12 | 2020 | 28 | |
| 13 | 2019 | 5 | |
| 14 | 2014 | 12 | |
| 15 | 2014 | 11 | |
| 16 | 2013 | 44 | |
| 17 | 2009 | 1 | |
| 18 | 2007 | 17 | |
| 19 | 2007 | 11 | |
| 20 | 2003 | 37 |
About Erika Halášová
Erika Halášová is a scholar working on Chemical Health and Safety, Cancer Research and Pharmacy, having authored 82 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroscience of respiration and sleep (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers), Infant Health and Development (7 papers), Respiratory and Cough-Related Research (7 papers), DNA Repair Mechanisms (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Chemical Health and Safety (18 citations), Endocrine and Autonomic Systems (172 citations) and Pharmacy (96 citations). Erika Halášová has collaborated with scholars based in Slovakia, Czechia and Germany. Frequent co-authors include Henrieta Škovierová, Dana Dvorská, Dušan Braný, Ján Lehotský, Eva Vidomanová, A Drgová, Silvia Mahmood, Ivan Poliaček, Z Tomori and A Stránský. Their work appears in journals such as Scientific Reports, Brain Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.